Christopher S. Fraser
Affiliations: | Molecular and Cellular Biology | University of California, Davis, Davis, CA |
Website:
http://biosci3.ucdavis.edu/Faculty/Profile/View/369Google:
"Christopher S. Fraser"Bio:
https://www.mcb.ucdavis.edu/faculty-labs/fraser/Home.html
http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.285080
Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Villa N, Fraser CS. (2023) Human eukaryotic initiation factor 4G directly binds the 40S ribosomal subunit to promote efficient translation. Biorxiv : the Preprint Server For Biology |
| O'Sullivan MH, Fraser CS. (2023) Monitoring RNA restructuring in a human cell-free extract reveals eIF4A-dependent and eIF4A-independent unwinding activity. The Journal of Biological Chemistry. 104936 |
| Lipo E, Asrat S, Huo W, et al. (2022) 5' Untranslated mRNA Regions Allow Bypass of Host Cell Translation Inhibition by Legionella pneumophila. Infection and Immunity. e0017922 |
| Izidoro MS, Sokabe M, Villa N, et al. (2022) Human eukaryotic initiation factor 4E (eIF4E) and the nucleotide-bound state of eIF4A regulate eIF4F binding to RNA. The Journal of Biological Chemistry. 102368 |
| Lapointe CP, Grosely R, Sokabe M, et al. (2022) eIF5B and eIF1A reorient initiator tRNA to allow ribosomal subunit joining. Nature |
| Brito Querido J, Sokabe M, Kraatz S, et al. (2020) Structure of a human 48 translational initiation complex. Science (New York, N.Y.). 369: 1220-1227 |
| Cunningham EB, Hajarizadeh B, Amin J, et al. (2020) Reinfection following successful direct-acting antiviral therapy for hepatitis C infection among people who inject drugs. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America |
| Howard CM, Bearss N, Subramaniyan B, et al. (2019) The CXCR4-LASP1-eIF4F Axis Promotes Translation of Oncogenic Proteins in Triple-Negative Breast Cancer Cells. Frontiers in Oncology. 9: 284 |
| Grebely J, Conway B, Cunningham EB, et al. (2018) Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy. The International Journal On Drug Policy. 62: 94-103 |
| Avanzino BC, Jue H, Miller CM, et al. (2018) Molecular mechanism of poliovirus Sabin vaccine strain attenuation. The Journal of Biological Chemistry |